European Journal of Internal Medicine
Volume 19, Issue 3 , Pages 214-215 , May 2008

Pulmonary embolism associated with the use of anabolic steroids

  • Sissela Liljeqvist

      Affiliations

    • Department of Internal Medicine, Karolinska Institutet, Södersjukhuset, SE-118 83, Stockholm, Sweden
    • ,
  • Anders Helldén

      Affiliations

    • Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital, SE-141 86, Huddinge, Sweden
    • ,
  • Ulf Bergman

      Affiliations

    • Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital, SE-141 86, Huddinge, Sweden
    • ,
  • Mårten Söderberg

      Affiliations

    • Department of Internal Medicine, Karolinska Institutet, Södersjukhuset, SE-118 83, Stockholm, Sweden
    • Corresponding Author InformationCorresponding author. Tel.: +46 8 616 3129; fax: +46 8 616 3146.

Received 10 January 2007 ,Accepted 9 March 2007.

References 

  1. Heit JA. Venous thromboembolism: disease burden, outcomes and risk factors. J Thromb Haemost. 2005;3:1611–1617
  2. Evans NA. Current concepts in anabolic–androgenic steroids. Am J Sports Med. 2004;32:534–542
  3. Melchert RB, Welder AA. Cardiovascular effects of androgenic–anabolic steroids. Med Sci Sports Exerc. 1995;27:1252–1262
  4. Lowe GDO. Hormone replacement therapy: prothrombotic vs. protective effects. Pathophysiol Haemost Thromb. 2002;32:329–332
  5. Eklöf AC, Thurelius AM, Garle M, Rane A, Sjöqvist F. The anti-doping hot-line, a means to capture the abuse of doping agents in the Swedish society and a new service function in clinical pharmacology. Eur J Clin Pharmacol. 2003;59:571–577

PII: S0953-6205(07)00232-4

doi: 10.1016/j.ejim.2007.03.016

European Journal of Internal Medicine
Volume 19, Issue 3 , Pages 214-215 , May 2008

Article Tools

* Image Usage & Resolution